Challenges in the implementation of chronic obstructive pulmonary disease guidelines in low- And middle-income countries an official American thoracic society workshop report

Mortimer, K.; Hurst, J.R.; Rylance, S.; Gianella, G.E.; Checkley, W.; Siddharthan, T.; Singh, S.J.; Khoo, E.M.; Mendes, R.G.; Buist, A.S.; Kirenga, B.; Mohan, A.; Zhang, J.; Van Boven, J.F.M.V.; Gaga, M.; Williams, S.

dc.contributor.author	Hurst, J.R.
dc.contributor.author	Buist, A.S.
dc.contributor.author	Gaga, M.
dc.contributor.author	Gianella, G.E.
dc.contributor.author	Kirenga, B.
dc.contributor.author	Khoo, E.M.
dc.contributor.author	Mendes, R.G.
dc.contributor.author	Mohan, A.
dc.contributor.author	Mortimer, K.
dc.contributor.author	Rylance, S.
dc.contributor.author	Siddharthan, T.
dc.contributor.author	Singh, S.J.
dc.contributor.author	Van Boven, J.F.M.V.
dc.contributor.author	Williams, S.
dc.contributor.author	Zhang, J.
dc.contributor.author	Checkley, W.
dc.date.accessioned	2021-10-04T23:00:56Z
dc.date.available	2021-10-04T23:00:56Z
dc.date.issued	2021
dc.identifier.uri	https://hdl.handle.net/20.500.12866/9793
dc.description.abstract	There is a substantial burden of chronic respiratory diseases, including chronic obstructive pulmonary disease (COPD), in lowand middle-income countries (LMICs). LMICs have particular challenges in delivering cost-effective prevention, diagnosis, and management of COPD. Optimal care can be supported by effective implementation of guidelines. This American Thoracic Society workshop considered challenges to implementation of COPD guidelines in LMICs. We make 10 specific recommendations: 1) relevant organizations should provide LMIC-specific COPD management guidance; 2) patient and professional organizations must persuade policy-makers of the importance of lung function testing programs in LMICs; 3) healthcare education and training should emphasize the early-life origins of COPD; 4) urgent action is required by governments to reduce airborne exposures, including exposures to tobacco smoke and indoor and outdoor air pollution; 5) guidance for COPD in LMICs should explicitly link across Essential Medicine Lists and the World Health Organization package of essential noncommunicable disease interventions for primary health care in low-resource settings and should consider availability, affordability, sustainability, and cost-effective use of medicines; 6) the pharmaceutical industry should work to make effective COPD and tobacco-dependence medicines globally accessible and affordable; 7) implementation of locally adapted, cost-effective pulmonary rehabilitation programs should be an international priority; 8) the World Health Organization Global Action Plan for the Prevention and Control of Noncommunicable Diseases should specify how improvements in respiratory health will be achieved; 9) research funders should increase the proportion of funding allocated to COPD in LMICs; and 10) the respiratory community should leverage the skills and enthusiasm of earliercareer clinicians and researchers to improve global respiratory health	en_US
dc.language.iso	eng
dc.publisher	American Thoracic Society
dc.relation.ispartofseries	Annals of the American Thoracic Society
dc.rights	info:eu-repo/semantics/restrictedAccess
dc.subject	Chronic obstructive pulmonary disease	en_US
dc.subject	Guidelines	en_US
dc.subject	Implementation	en_US
dc.subject	Low- and middle-income countries	en_US
dc.title	Challenges in the implementation of chronic obstructive pulmonary disease guidelines in low- And middle-income countries an official American thoracic society workshop report	en_US
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	https://doi.org/10.1513/AnnalsATS.202103-284ST
dc.subject.ocde	https://purl.org/pe-repo/ocde/ford#3.02.07
dc.relation.issn	2325-6621